Medical Device Cleaning and Disinfecting Market Size, Share, Growth and Industry Analysis, By Types (Presoak/Pre-Cleaning and Disinfecting, Manual Cleaning and Disinfecting, Automatic Cleaning and Disinfecting, Others), By Applications (Surgical Instruments, Endoscopes, Ultrasound Probes, Other Instruments), Regional Insights and Forecast to 2035

Medical Device Cleaning and Disinfecting Market Size

The Global Medical Device Cleaning and Disinfecting Market was valued at USD 92.4 million in 2025 and is projected to reach USD 97.02 million in 2026 and USD 101.87 million in 2027, before expanding to USD 150.51 million by 2035, registering a CAGR of 5.0% during the forecast period from 2026 to 2035. The Medical Device Cleaning and Disinfecting Market is experiencing steady growth due to the rising number of surgical and diagnostic procedures, stricter infection prevention standards, and increasing focus on reducing healthcare-associated infections across healthcare facilities. Growing adoption of automated reprocessing technologies, environmentally friendly disinfectants, and advanced cleaning solutions is further supporting market expansion. In addition, the need to ensure patient safety, maintain regulatory compliance, extend the operational life of reusable medical devices, and improve overall clinical efficiency continues to strengthen demand for Medical Device Cleaning and Disinfecting Market solutions worldwide. This combination of regulatory support, technological innovation, and expanding healthcare infrastructure is expected to sustain long-term market growth.

The US Medical Device Cleaning and Disinfecting Market is experiencing robust growth, driven by healthcare facility modernization, rising surgical procedures, and stricter infection prevention requirements. Approximately 36% of U.S. healthcare operators have upgraded cleaning and disinfection systems in line with advanced hygiene requirements. Healthcare facilities are also shifting toward automated and AI-enabled reprocessing systems for surgical and diagnostic instruments. Around 33% of hospitals performing intensive procedures now implement advanced cleaning systems adhering to strict sterilization standards, ensuring durability and sterility in critical treatment environments. Public and private investments continue to rise, reinforcing the region’s leadership in advanced medical device reprocessing technology.

Japan Medical Device Cleaning and Disinfecting Market is witnessing strong growth, supported by the country's rapidly aging population, increasing prevalence of chronic diseases, and rising number of surgical and diagnostic procedures that require strict infection prevention protocols. Government emphasis on patient safety, hospital-acquired infection (HAI) reduction, and compliance with stringent healthcare regulations is accelerating the adoption of advanced cleaning, disinfection, and automated reprocessing technologies. Continuous investments in healthcare infrastructure, expansion of medical device manufacturing, and growing demand for high-level disinfection solutions are further strengthening the Japan Medical Device Cleaning and Disinfecting Market. These factors are expected to create sustained growth opportunities as healthcare providers increasingly prioritize efficient, compliant, and high-quality device reprocessing solutions.

Key Findings

• Market Size: Valued at $92.4M in 2025, projected to touch $97.02M in 2026 to $150.51M by 2035 at a CAGR of 5%.
• Growth Drivers: ~34% of demand driven by infection control investment; ~37% usage tied to enzymatic cleaning products.
• Trends: Automated washer-disinfectors account for ~41% of technique share; UV/Ozone technologies growing in ~25% of facilities.
• Key Players: Steris plc., 3M Company, Getinge AB, Ecolab, Cantel Medical Corp & more.
• Regional Insights: North America ~34%, Europe ~28%, Asia-Pacific ~22%, others ~16% of total market.
• Challenges: ~25–30% of smaller facilities constrained by high equipment and compliance costs.
• Industry Impact: Facilities using automated systems saw ~30–45% reduction in microbial carryover and increased workflow consistency.
• Recent Developments: High-level disinfection and sterilization uptake in ~53% of applications; critical device cleaning fastest-growing segment at ~48% share.

Medical Device Cleaning and Disinfecting Market Trends

The Medical Device Cleaning and Disinfecting market is undergoing strong transformation driven by heightened infection control awareness and regulatory mandates in healthcare. Approximately 65% of hospitals now emphasize advanced cleaning protocols for critical surgical instruments and endoscopes to minimize contamination. Endoscope reprocessing has grown to account for around 30% of all device cleaning cycles, owing to stringent hygiene standards. Automated washer-disinfectors constitute roughly 40% of investable reprocessing equipment, while manual practices remain at 55% in low-resource settings. Pre-soak/pre-clean solutions are used in 25% of device preparations before final disinfection. In recent deployments, nearly 35% of healthcare facilities have incorporated ultrasonic cleaning devices for probes and flexible instruments. Advanced infection prevention considerations are increasingly embedded into cleaning protocols, with approximately 20% of institutions adopting disinfectants approved for sensitive clinical environments. Demand for enzyme-based detergents used in pre-cleaning steps has risen by about 28%, and the use of high-level disinfectants such as peracetic acid and hydrogen peroxide-based systems is prevalent in 45% of sterilization workflows. These trends reflect the industry’s alignment with patient safety imperatives and regulatory compliance around device processing and product selection.

Medical Device Cleaning and Disinfecting Market Dynamics

DRIVERS

Heightened infection control protocols

Protocols now require that nearly 70% of reprocessing departments follow multi-step cleaning and disinfecting workflows. Surgeons and facility managers report a 50% reduction in device-associated infections where high-level disinfectants and validated cleaning have been implemented. Infection control compliance drives additional scrutiny around disinfectant residues and biocompatibility.

OPPORTUNITY

Automation and enzyme-based cleaning expansion

Automated cleaning systems represent about 40% of all new equipment installations, with enzyme detergents used in roughly 28% of pre-clean processes. Facilities that switched to ultrasonic and washer-disinfector combos noted a nearly 30% improvement in throughput and compliance, and advanced reprocessing protocols support use of enzyme systems for reduced chemical residue.

RESTRAINTS

"Reliance on manual reprocessing practices"

Manual cleaning and disinfection remain dominant, especially in low-income regions where automated devices are either unaffordable or unavailable. Around 55% of facilities still rely primarily on manual cleaning cycles. Smaller facilities report that approximately 35% of their cleaning issues stem from inconsistent manual protocols and technician error. This reinforces the need for training and protocol standardization to align with healthcare environment expectations and reduce risk.

CHALLENGE

"Compatibility with advanced medical materials"

Probing deeper into design, modern devices often include advanced polymers and electronics that demand specific cleaning solutions. Nearly 40% of new medical devices require low-temperature cleaning agents to protect delicate components. However, about 25% of older disinfectants pose compatibility risks, risking surface degradation or residual toxicity. Regulatory compliance mandates safer residue profiles, yet device-material mismatch continues to be a challenge in roughly 22% of reprocessing workflows.

Segmentation Analysis

The market is segmented by cleaning methodology and end-use device category, reflecting varied needs across surgical wards, endoscopy units, and diagnostic labs. Types include pre-soak/pre-clean solutions, manual cleaning, automated systems, and others such as ultrasonic or thermal washers. Applications span surgical instruments, endoscopes, ultrasound probes, and miscellaneous instruments. Advanced infection-control protocols influence selection, particularly in sterilization steps involving high-level disinfectants for reusable devices used near open wounds or sterile procedures. Each segment exhibits different adoption rates tied to facility size, resource availability, and regulatory stringency.

By Type

• Presoak/Pre-Cleaning and Disinfecting: Used in about 25% of all reprocessing routines, presoak solutions soften soils and reduce bioburden before manual or automated cleaning. They are increasingly enzyme-based, accounting for nearly 28% of usage in high-volume hospitals, improving cleaning efficacy and aligning with advanced hygiene standards by minimizing residuals.
• Manual Cleaning and Disinfecting: Still dominant in around 55% of facilities globally, manual methods involve brushing and soaking with detergents and disinfectants. However, only about 40% of facilities report full compliance with validated protocols, leading to inconsistency and infection risk—particularly critical in surgical instrument cleaning with stringent hygiene mandates.
• Automatic Cleaning and Disinfecting: Accounts for approximately 40% of new equipment deployments, with washer-disinfectors and ultrasonic systems gaining traction. Facilities using automated systems note up to a 30% increase in processing efficiency and a 45% reduction in microbial carryover, supporting stringent infection-control workflows.
• Others: Includes thermal disinfection, UV-based systems, and emerging technologies used in about 10% of high-end facilities. Some high-capacity endoscopy units deploy UV-C chambers or thermal cycles that achieve log-level microbial reductions and are compatible with critical healthcare areas.

By Application

• Surgical Instruments: Surgical tools represent roughly 35% of cleaning cycles; high-level disinfectants are used in 50% of specialty procedure cases—especially in sterile environments where bioburden control is critical near incision sites.
• Endoscopes: Endoscope cleaning accounts for about 30% of reprocessing volume. Around 60% of endoscopy units have adopted automated channels or automated endoscope reprocessors (AERs) to ensure consistent high-level disinfection and compliance with patient safety protocols.
• Ultrasound Probes: Constituting about 15% of usages, disinfection of probes is increasingly important in obstetrics and interventional applications. 40% of facilities use single-use probe covers combined with low-temperature disinfectants to meet strict safety and hygiene requirements.
• Other Instruments: Other reusable devices such as orthopedic drills and dental instruments account for 20% of usage. Many facilities now use automated or integrated cleaning workflows—about 30% of dental and specialty clinics have shifted from manual to automated cleaning to improve compliance.

Regional Outlook

The Medical Device Cleaning and Disinfecting market displays region-specific adoption patterns influenced by healthcare infrastructure maturity, regulatory regimes, and infection control policies. North America leads adoption with advanced sterile processing departments, while Europe closely follows with robust hospital accreditation standards. Asia-Pacific is rapidly modernizing its facilities, embracing automated cleaning technologies in tier-1 and tier-2 hospitals. Middle East & Africa exhibit slower uptake but show growing interest in centralized sterilization services and advanced cleaning protocols. Regional investments prioritize scaling automated systems and training, which reflects rising surgical volumes and global attention to patient safety.

North America

North America represents about 35% of global cleaning and disinfection activity. Approximately 70% of large hospitals are equipped with automated washer-disinfectors, and around 60% employ enzyme-based pre-cleaning solutions standard in surgical device workflows. Infection control compliance is embedded into central sterile processing protocols in close to 50% of healthcare institutions, with regular audits and validation programs in place to ensure device safety and biocompatibility.

Europe

Europe accounts for roughly 30% of the global market. Nearly 65% of European hospitals operate validated automated endoscope reprocessing units, and 55% use enzyme detergents in cleaning pre-steps. Infection prevention considerations influence selection of disinfectants approved for low residue and high biocompatibility in surgical and endoscopy departments in approximately 45% of facilities.

Asia-Pacific

Asia-Pacific contributes about 25% of global device cleaning activity. While manual cleaning remains prevalent in around 50% of smaller hospitals, adoption of automated systems is growing in larger healthcare centers—accounting for nearly 35% of installations. Enzyme-based detergents are used in about 30% of cases, especially in private and tertiary hospitals. Advanced cleaning protocols are incorporated in around 20% of leading institutions, focusing on patient safety and infection prevention.

Middle East & Africa

Middle East & Africa cover approximately 10% of the market. Automated cleaning systems are available in only 25% of major hospitals, while enzyme detergents are used in 30% of facilities adopting modern reprocessing standards. Infection control policies are emerging, with around 15% of leading hospitals implementing validated workflows for critical surgical and endoscopy instrument reprocessing.

LIST OF KEY Medical Device Cleaning and Disinfecting Market COMPANIES PROFILED